拓新药业 (301089.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(拓新药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) --1.00--2.001.00---
 单季度销售毛利率(%) 26.00-41.0028.0037.0083.0077.0054.0036.0044.00
 单季度销售净利率(%) 2.00-78.004.005.0055.0049.0031.0022.0022.00
 单季度净资产收益率ROE(%) --4.00--20.0014.005.002.003.00
 单季度总资产净利率ROA(%) --4.00--16.0011.004.002.002.00
单季度财务摘要:
 单季度营业总收入(元) 108,322,507.0089,382,087.0089,151,675.00105,969,013.00551,007,176.00361,801,546.00176,274,055.00117,097,002.00129,549,460.00
 单季度营业总成本(元) 111,604,696.00150,714,508.00110,356,588.00110,798,606.00145,292,582.00152,976,504.00111,343,562.00103,970,584.0099,120,823.00
 单季度营业收入(元) 108,322,507.0089,382,087.0089,151,675.00105,969,013.00551,007,176.00361,801,546.00176,274,055.00117,097,002.00129,549,460.00
 单季度营业利润(元) 2,476,875.00-60,212,208.00-15,723,764.00-3,571,658.00401,191,562.00200,551,770.0071,753,418.0021,478,148.0035,508,297.00
 单季度利润总额(元) 2,452,206.00-63,081,740.00-15,969,198.00-3,920,501.00399,504,808.00197,720,022.0071,426,374.0021,038,266.0035,085,124.00
 单季度净利润(元) 2,068,382.00-70,118,099.003,657,889.005,226,715.00304,306,230.00177,050,537.0055,428,313.0025,617,372.0028,439,239.00
 单季度归属母公司股东的净利润(元) 2,068,382.00-70,118,099.003,657,889.005,226,715.00304,306,230.00177,050,537.0055,428,313.0025,617,372.0028,439,239.00
 单季度经营活动产生的现金流量(元) 52,145,491.00-25,638,229.002,876,168.00-56,344,735.00106,060,160.00204,265,784.0067,908,121.00-251,641.00-3,072,039.00
 单季度投资活动产生的现金流量(元) 106,032,689.00-154,140,640.00199,602,145.00-97,601,949.00-76,467,201.00-90,783,741.00-122,622,323.0013,302,718.0037,691,426.00
 单季度筹资活动产生的现金流量(元) -21,624,205.00--60,480,694.00-30,215,833.00-38,651,668.00-36,712,375.0031,586,308.003,379,893.00
 单季度现金及现金等价物净增加(元) 158,434,973.00-158,044,941.00202,478,313.00-214,120,132.00-928,468.0074,907,694.00-90,576,418.0044,671,612.0038,008,815.00

前瞻产业研究院